Canadian Clinical Trial Summit: Starting the conversation E-mail

Saryeddine, T., Brimacombe, G., Laberge, N., Taylor, D.W., Kumar, R., Arts, K., Bennett, L., Ferdinand, M. 2011.

This document is designed to introduce a conversation. Considering that the focus of the summit will be on action plan development, the organizers felt it may be helpful and efficient to summarize commonly known issues and assumptions that will likely underpin the conversation. In this document, we discuss the value of clinical trials to Canada; what other countries are doing to attract them; what the situation looks like in our country; possible issues and explanations for recent trends; an overview of our strengths, and a look at current initiatives at both the national and provincial levels.

Medicaid in a New Era - Presentation by Robert Freeman E-mail

Medicaid in a new era - Robert Freeman from PFCD on Vimeo.

Click the link above to watch Robert Freeman's presentation at 'Medicaid in a new era:  proven solutions that enhance quality and reduce costs."  This event was co-hosted by the Partnership to Fight Chronic Disease and UnitedHealthcare. 

Robert Freeman was presenting the results of a Cameron Institute research paper 'The Effectiveness of Disease Management Programs in the Medicaid Population'.  Robert Freeman is a research associate with the Cameron Institute.

The Effectiveness of Disease Management Programs in the Medicaid Population E-mail

Robert Freeman, Ph.D., Kristina M. Lybecker, Ph.D., D. Wayne Taylor, Ph.D., F.CIM

Executive Summary

In the midst of rising health care expenditures, increasingly limited health care budgets and economic uncertainty, the efficient use of government funds and other resources is of the utmost importance.  In March 2010, the Patient Protection and Affordable Care Act (ACA) expanded Medicaid, to help reduce the number of uninsured, thus potentially further increasing tremendously the fiscal burden on the states.  According to the Office of the Actuary of the Centers for Medicare and Medicaid Services the states’ Medicaid programs spending is forecast to increase by an annual rate of 8.4% from 2009 to 2019.
Some of the cost increase is due to the inefficiencies inherent in the highly fragmented nature of the delivery of Medicaid between state and private enterprise, between stand-alone and co-ordinated services models, between individual and population health management strategies, and among the 50 states themselves.

Generic-drug ‘solution’ for Africa not needed E-mail

Opinion in the Hamilton Spectator
February 3, 2011

Generic-drug ‘solution’ for Africa not needed
Prices and patents are not the issue in getting medicines to people in developing countries

Although it is commendable that Canadian Parliamentarians wish to do their part in saving lives around the world, private member’s Bill C-393, being debated in the House of Commons, is not the route to follow.

The mad, mad world of pharmacare in Canada: access to newer treatments for atrial fibrillation E-mail

There is an old saying in political science, “if you change the language, you change the debate.” This has happened in Canada. Everyone is told, and most believe, that the number one driver of healthcare costs is drugs. This is just not true. The number one driver of healthcare costs is our health. Spending on drugs is a good thing. We are very lucky that medical therapies multiplied in number just as we were closing 36% of our hospital beds across Canada in the 1990’s.

<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>

Page 4 of 9

Latest News

Ontario Morning